Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Replacement: Director/PDMR Shareholding

20 May 2016 14:33

RNS Number : 9068Y
Cello Group plc
20 May 2016
 

The following amendments have been made to the 'Director's Dealing' announcement released on 20 May 2016 at 1.30 pm under RNS No 9009Y.

 

The number of ordinary shares sold by Mark Bentley was 77,511, as opposed to 77,476 as previously announced. Accordingly, Mr Bentley's retained interest in ordinary shares is now 337,968, as opposed to 338,003 as previously announced.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

 

20 May 2016

Cello Group plc

("Cello" or the "Company")

 

Director's dealing

 

The Company has been notified that on 20 May 2016 the following directors of the Company exercised options under the PSP Option Scheme 2010 ("PSP") and the Approved Share Option Plan 2009 ("Approved") in order to increase their stakes in the Company.

Details of the exercise of options by the directors are set out below:

Director

Option Scheme

No of options held prior to exercise

No of options exercised

Exercise Price

No of options held post exercise

Mark Scott

PSP

1,550,000

770,000

10p

780,000

Mark Scott

Approved

72,000

72,000

31.5p

-

Mark Bentley

PSP

605,000

130,000

10p

475,000

Stephen Highley

PSP

420,000

50,000

10p

370,000

 

Following the exercise of these options the directors made the following sale of ordinary shares of 10 pence each in the Company ("Ordinary Shares"), these sales were made to cover exercise, tax and national insurance costs:

Director

No of ordinary shares prior to exercise and sale

No of ordinary shares sold

Sale Price

Retained interest in ordinary shares

% of issued share capital (as enlarged by the issue of options)

Mark Scott

964,379

486,204

97.2p

1,320,175

1.52%

Mark Bentley

285,479

77,511

97.2p

337,968

0.39%

Stephen Highley

2,046,889

22,285

97.2p

2,074,604

2.39%

 

 Contacts:

 

 Cello Group 020 7812 8460

 Mark Scott, Chief Executive

 Mark Bentley, Finance Director

 

 Cenkos Securities 0207 397 8900

 Bobbie Hilliam

 Harry Pardoe

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFFVEDIIFIR
Date   Source Headline
6th Jul 20204:59 pmPRNForm 8.3 - Cello Health Plc
6th Jul 20203:45 pmRNSForm 8.3 - Cello Health plc
6th Jul 20203:13 pmRNSForm 8.3 - CELLO HEALTH PLC
6th Jul 20203:00 pmBUSForm 8.3 - Cello Health Plc
6th Jul 202012:15 pmRNSForm 8.3 - Cello Health Plc
6th Jul 20207:00 amRNSUpdate on irrevocable undertakings
3rd Jul 20203:20 pmRNSForm 8.3 - Cello Health
3rd Jul 20203:16 pmRNSForm 8.3 - CELLO HEALTH PLC
3rd Jul 20203:00 pmBUSForm 8.3 - Cello Health Plc
3rd Jul 20202:30 pmRNSForm 8.3 - Cello Health PLC
3rd Jul 202011:53 amRNSForm 8.3 - Cello Health Plc
3rd Jul 20209:36 amRNSForm 8.3 - Cello Health Plc
3rd Jul 20207:00 amRNSReplacement - Form 8 (OPD) - Cello Health plc
3rd Jul 20207:00 amRNSForm 8.3 - Cello Health PLC
2nd Jul 20206:26 pmRNSForm 8.3 - Cello Health plc
2nd Jul 20203:20 pmRNSForm 8.3 - Cello Health
2nd Jul 20202:29 pmRNSForm 8.3 - CELLO GROUP PLC
2nd Jul 20201:07 pmRNSForm 8.3 - Cello Health Plc
2nd Jul 202012:17 pmRNSForm 8.3 - Cello Health Plc
2nd Jul 202010:57 amRNSForm 8.3 - CELLO HEALTH PLC
2nd Jul 202010:26 amGNWForm 8.3 - [Cello Health plc - Opening Declaration] - (HH Ltd)
2nd Jul 202010:25 amRNSForm 8.3 - Cello Health Plc
2nd Jul 20208:53 amRNSForm 8.5 (EPT/NON-RI)
2nd Jul 20207:00 amRNSUpdate on letters of intent
2nd Jul 20207:00 amRNSForm 8 (OPD) - Cello Health plc
1st Jul 20205:21 pmGNWForm 8.3 - Cello Health plc
1st Jul 20203:31 pmPRNForm 8.3 - Cello Health
1st Jul 20209:05 amRNSForm 8.3 - Cello Health plc
1st Jul 20207:00 amRNSRECOMMENDED CASH OFFER
15th Jun 202010:09 amRNSHolding(s) in Company
11th Jun 20203:48 pmRNSHolding(s) in Company
20th May 20201:05 pmRNSResult of AGM
20th May 20207:00 amRNSAGM Statement
5th May 20207:00 amRNSIssue of Equity
21st Apr 20207:00 amRNSAnnual Report and Notice of AGM
17th Apr 20209:46 amRNSTotal Voting Rights
14th Apr 20205:18 pmRNSHolding(s) in Company
7th Apr 20207:00 amRNSCOVID-19 Update
30th Mar 20209:37 amRNSGrant of Options
18th Mar 20207:00 amRNSPreliminary Results
7th Feb 202012:19 pmRNSHolding(s) in Company
6th Feb 20207:00 amRNSSettlement with Access Intelligence
22nd Jan 20204:40 pmRNSBlock listing Interim Review
16th Jan 20207:00 amRNSPre-Close Trading Statement
3rd Dec 20193:09 pmRNSTotal Voting Rights
22nd Nov 20194:55 pmRNSHolding(s) in Company
14th Nov 20199:30 amRNSHolding(s) in Company
13th Nov 20195:00 pmRNSTotal Voting Rights
7th Oct 20191:39 pmRNSHolding(s) in Company
7th Oct 20191:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.